Google
AEON — AEON BIOPHARMA, INC. (Healthcare >> Biotechnology)
AEON FAQ
What is AEON's ROE?
AEON BIOPHARMA, INC. reports a Return on Equity (ROE) of 358.82%.
What is AEON's dividend yield?
AEON BIOPHARMA, INC. offers a dividend yield of 0.00%.
What is AEON's Deepscope Quality Score?
Deepscope rates AEON's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy AEON?
Deepscope's AI Timing Score for AEON is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does AEON belong to?
AEON BIOPHARMA, INC. is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 0.75
Price
0.00
(0.03%)
Day Change
|
|
|---|
AEON, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROA is relatively low.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 82 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.75 |
| PBV / Sector |
-1.16 / 4.53
|
| Earning Per Share | -2.32 |
| PE / Sector |
N/A / 16.80
|
| PEG or PE/Growth / Sector |
N/A / 0.51
|
| Average 1M Daily Value |
0.05 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-03 09:10:59 |
| Symbol | AEON |
| Name | AEON BIOPHARMA, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 26.31 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 19.46 / 8,614.17 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 5 Park Plaza, Irvine, CA, United States, 92614
Phone: 949 354 6499
Website: https://www.aeonbiopharma.com
Sector: Healthcare >> Biotechnology
Description: AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
